Medtronic PLC is a global leader in medical technology, dedicated to alleviating pain, restoring health, and extending life for patients worldwide. The company's mission is to contribute to human welfare by applying biomedical engineering to the diagnosis, treatment, and monitoring of health conditions. Medtronic's strategy focuses on innovation and collaboration, developing advanced medical devices and therapies across various sectors, including cardiovascular, diabetes, and neurological care. With a commitment to improving patient outcomes, Medtronic operates in over 150 countries, leveraging cutting-edge technology and research to enhance healthcare delivery and accessibility.

MEDTRONIC PLC

Medtronic's shares experienced a notable decline of 7.3% following the release of its fiscal 2025 third-quarter results, which revealed revenues of $8.3 billion—slightly lower than analyst expectations. However, on a brighter note, the company reported adjusted earnings per share (EPS) of $1.39, exceeding forecasts and demonstrating effective cost management. CEO...

Medtronic Shares Drop Over 7% Amid Mixed Q3 Results, Despite Exceeding EPS Expectations and Strong Dividend Potential

Medtronic's recent Q3 results reveal a complex picture: while adjusted EPS surpassed expectations, a 7.3% drop in shares highlights revenue challenges. Can the company's strong dividend history and growth in the diabetes segment offset the current market uncertainties?